These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
445 related articles for article (PubMed ID: 18172253)
1. Vascular endothelial growth factor gene polymorphisms associated with prognosis for patients with colorectal cancer. Kim JG; Chae YS; Sohn SK; Cho YY; Moon JH; Park JY; Jeon SW; Lee IT; Choi GS; Jun SH Clin Cancer Res; 2008 Jan; 14(1):62-6. PubMed ID: 18172253 [TBL] [Abstract][Full Text] [Related]
2. Common polymorphisms in the vascular endothelial growth factor gene and colorectal cancer development, prognosis, and survival. Dassoulas K; Gazouli M; Rizos S; Theodoropoulos G; Christoni Z; Nikiteas N; Karakitsos P Mol Carcinog; 2009 Jun; 48(6):563-9. PubMed ID: 19009560 [TBL] [Abstract][Full Text] [Related]
3. Gastric cancer risk predisposition and prognostic significance of vascular endothelial growth factor (VEGF) gene polymorphisms--a case-control study in an Omani population. Al-Moundhri MS; Al-Nabhani M; Burney IA; Al-Farsi AA; Al-Bahrani B Mol Carcinog; 2009 Dec; 48(12):1170-6. PubMed ID: 19676106 [TBL] [Abstract][Full Text] [Related]
4. Vascular endothelial growth factor polymorphisms in relation to breast cancer development and prognosis. Jin Q; Hemminki K; Enquist K; Lenner P; Grzybowska E; Klaes R; Henriksson R; Chen B; Pamula J; Pekala W; Zientek H; Rogozinska-Szczepka J; Utracka-Hutka B; Hallmans G; Försti A Clin Cancer Res; 2005 May; 11(10):3647-53. PubMed ID: 15897560 [TBL] [Abstract][Full Text] [Related]
5. Vascular endothelial growth factor gene polymorphisms are associated with the risk of developing adenomyosis. Kang S; Zhao J; Liu Q; Zhou R; Wang N; Li Y Environ Mol Mutagen; 2009 Jun; 50(5):361-6. PubMed ID: 19197986 [TBL] [Abstract][Full Text] [Related]
6. The relationship of VEGF polymorphisms with serum VEGF levels and progression-free survival in patients with epithelial ovarian cancer. Steffensen KD; Waldstrøm M; Brandslund I; Jakobsen A Gynecol Oncol; 2010 Apr; 117(1):109-16. PubMed ID: 20056267 [TBL] [Abstract][Full Text] [Related]
7. VEGF polymorphisms and survival in early-stage non-small-cell lung cancer. Heist RS; Zhai R; Liu G; Zhou W; Lin X; Su L; Asomaning K; Lynch TJ; Wain JC; Christiani DC J Clin Oncol; 2008 Feb; 26(6):856-62. PubMed ID: 18281657 [TBL] [Abstract][Full Text] [Related]
8. E-selectin gene S128R polymorphism is associated with poor prognosis in patients with stage II or III colorectal cancer. Hebbar M; Adenis A; Révillion F; Duhamel A; Romano O; Truant S; Libersa C; Giraud C; Triboulet JP; Pruvot FR; Peyrat JP Eur J Cancer; 2009 Jul; 45(10):1871-6. PubMed ID: 19361981 [TBL] [Abstract][Full Text] [Related]
9. Association of VEGF and KDR single nucleotide polymorphisms with colorectal cancer susceptibility in Koreans. Jang MJ; Jeon YJ; Kim JW; Cho YK; Lee SK; Hwang SG; Oh D; Kim NK Mol Carcinog; 2013 Nov; 52 Suppl 1():E60-9. PubMed ID: 23169005 [TBL] [Abstract][Full Text] [Related]
10. Association between vascular endothelial growth factor gene polymorphisms and age-related macular degeneration in a Polish population. Janik-Papis K; Zaras M; Krzyzanowska A; Wozniak K; Blasiak J; Szaflik J; Szaflik JP Exp Mol Pathol; 2009 Dec; 87(3):234-8. PubMed ID: 19761764 [TBL] [Abstract][Full Text] [Related]
11. Associations of single nucleotide polymorphisms in the vascular endothelial growth factor gene with the characteristics and prognosis of renal cell carcinomas. Kawai Y; Sakano S; Korenaga Y; Eguchi S; Naito K Eur Urol; 2007 Oct; 52(4):1147-55. PubMed ID: 17287073 [TBL] [Abstract][Full Text] [Related]
12. Clinical significance of plasma level of vascular endothelial growth factor-C in patients with colorectal cancer. Miyazaki T; Okada N; Ishibashi K; Ogata K; Ohsawa T; Ishiguro T; Nakada H; Yokoyama M; Matsuki M; Kato H; Kuwano H; Ishida H Jpn J Clin Oncol; 2008 Dec; 38(12):839-43. PubMed ID: 18923001 [TBL] [Abstract][Full Text] [Related]
14. CyclinD1 and interleukin-1 receptor antagonist polymorphisms are associated with prognosis in neoadjuvant-treated gastric carcinoma. Stocker G; Ott K; Henningsen N; Becker K; Hapfelmeier A; Lordick F; Hois S; Plaschke S; Höfler H; Keller G Eur J Cancer; 2009 Dec; 45(18):3326-35. PubMed ID: 19822419 [TBL] [Abstract][Full Text] [Related]
15. Vascular endothelial growth factors C and D represent novel prognostic markers in colorectal carcinoma using quantitative image analysis. Hu WG; Li JW; Feng B; Beveridge M; Yue F; Lu AG; Ma JJ; Wang ML; Guo Y; Jin XL; Zheng MH Eur Surg Res; 2007; 39(4):229-38. PubMed ID: 17446709 [TBL] [Abstract][Full Text] [Related]
16. Association of VEGF genetic polymorphisms with prostate carcinoma risk and clinical outcome. Sfar S; Hassen E; Saad H; Mosbah F; Chouchane L Cytokine; 2006 Jul; 35(1-2):21-8. PubMed ID: 16908180 [TBL] [Abstract][Full Text] [Related]
17. Vascular endothelial growth factor polymorphisms in gastric cancer development, prognosis, and survival. Tzanakis N; Gazouli M; Rallis G; Giannopoulos G; Papaconstantinou I; Theodoropoulos G; Pikoulis E; Tsigris C; Karakitsos P; Peros G; Nikiteas N J Surg Oncol; 2006 Dec; 94(7):624-30. PubMed ID: 17111394 [TBL] [Abstract][Full Text] [Related]
18. Vascular endothelial growth factor genotypes, haplotypes, gender, and the risk of non-small cell lung cancer. Zhai R; Liu G; Zhou W; Su L; Heist RS; Lynch TJ; Wain JC; Asomaning K; Lin X; Christiani DC Clin Cancer Res; 2008 Jan; 14(2):612-7. PubMed ID: 18223238 [TBL] [Abstract][Full Text] [Related]
20. Association of genetic polymorphisms in the VEGF gene with breast cancer survival. Lu H; Shu XO; Cui Y; Kataoka N; Wen W; Cai Q; Ruan ZX; Gao YT; Zheng W Cancer Res; 2005 Jun; 65(12):5015-9. PubMed ID: 15958542 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]